Merus (MRUS) executive Shuman sold 5,000 shares for $270K at $54.00
Insider transactions reported
Harry Shuman (VP Controller, PAO at Merus N.V., MRUS) reported that they sold 5,000 shares for $270K at $54.00, and acquired 5,000 shares between Aug 20, 2024 and Aug 21, 2024. After these transactions the filing shows 7,002 shares held directly.
- Reporting person
- Shuman Harry
- Role
- VP Controller, PAO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 20, 2024 | Exercise or conversion of a derivative (M) | Common Shares1 | +2,500 | - | - | 9,502 direct |
| Aug 20, 2024 | Open-market sale (S) | Common Shares | -2,500 | $54.00 | $135K | 7,002 direct |
| Aug 21, 2024 | Exercise or conversion of a derivative (M) | Common Shares2 | +2,500 | - | - | 9,502 direct |
| Aug 21, 2024 | Open-market sale (S) | Common Shares | -2,500 | $54.00 | $135K | 7,002 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 20, 2024 | Exercise or conversion of a derivative (M) | Share Option (right to buy)On 2,500 Common Shares1, 3 | -2,500 | - | - | 10,200 direct |
| Aug 21, 2024 | Exercise or conversion of a derivative (M) | Share Option (right to buy)On 2,500 Common Shares2, 4 | -2,500 | - | - | 15,500 direct |
Holdings before and after
- Share Option (right to buy): 12,700 to 15,500 direct
Footnotes from the filing
- 1. Represents the exercise price of the options originally granted on February 14, 2020.
- 3. Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Shuman report in this MRUS Form 4?
Harry Shuman (VP Controller, PAO at Merus N.V., MRUS) reported that they sold 5,000 shares for $270K at $54.00, and acquired 5,000 shares between Aug 20, 2024 and Aug 21, 2024. After these transactions the filing shows 7,002 shares held directly.
How many MRUS shares does Shuman hold after this filing?
The filing shows 7,002 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this MRUS insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for MRUS
Earlier insider filings at MRUS
- Jul 3, 2024SEC Form 4 filed by Chief Medical Officer Zohren Fabian
- Jun 28, 2024COO & GC Silverman Peter B. exercised 10,000 shares at a strike of $17.94 and sold $600,000 worth of shares (10,000 units at $60.00) (SEC Form 4)
- Jun 20, 2024COO & GC Silverman Peter B. exercised 62,000 shares at a strike of $24.36 and sold $3,504,178 worth of shares (62,000 units at $56.52) (SEC Form 4)
- Jun 12, 2024VP Controller, PAO Shuman Harry sold $475,456 worth of shares (8,300 units at $57.28) and converted options into 8,300 shares (SEC Form 4)
- Jun 6, 2024Shuman Harry converted options into 6,000 shares and sold $317,354 worth of shares (6,000 units at $52.89) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Follow MRUS and get a push notification the moment its next story breaks.